1-5 of 5
Christopher E. Jensen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Treatment Effectiveness with Venetoclax-Based Therapy after Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: An International Real-World Study

Nilanjan Ghosh, Nicole Lamanna, Toby A. Eyre, Catherine C Coombs, Beenish S Manzoor, Jennifer R. Brown, Hande H. Tuncer, Chaitra S Ujjani, Lori A Leslie, Lindsey E. Roeker, Matthew S Davids, Joanna M. Rhodes, Alan Skarbnik, Nnadozie Emechebe, Isabelle Fleury, Brian T. Hill, Christopher P. Fox, Paul M. Barr, Dureshahwar Jawaid, Wendy J Sinai, Laurie K Pearson, Frederick Lansigan, Yun Choi, Christopher E. Jensen, Stephen J. Schuster, Kaitlin Kennard, Irina Pivneva, Talissa Watson, Annie Guerin, Mazyar Shadman
Journal: Blood
Blood (2023) 142 (Supplement 1): 1908.
https://doi.org/10.1182/blood-2023-179198
Published: 2023
Journal Articles

A Phase 2 Study of Minimal Residual Disease (MRD)-Adapted Front Line Venetoclax and Obinutuzumab in Fit Patients with Chronic Lymphocytic Leukemia (CLL): Effect of Obinutuzumab on Tumor Lysis Syndrome (TLS) Risk and Safety of Outpatient Venetoclax Dose Escalation

Lindsey E. Roeker, Andrew D. Zelenetz, Jae H. Park, Andriy Derkach, Mark Blaine Geyer, Prioty Islam, Lorenzo Falchi, Maria Lia Palomba, Anita Kumar, Gilles Salles, Jennifer Kimberly Lue, Aaron D. Goldberg, Bita Fakhri, Catherine C. Coombs, Victoria Falco, Gail Panton, Dianna Tyznar, Dhara Soni, Lauren Nogan, Sonia Lebowitz, Katherine Blesie, Monica Shah, Sarah Court, Christopher E. Jensen, Anthony R. Mato, Meghan C. Thompson
Journal: Blood
Blood (2023) 142 (Supplement 1): 4657.
https://doi.org/10.1182/blood-2023-181661
Published: 2023
Journal Articles

Functional Status and Mortality Among Older Adults with Multiple Myeloma

Christopher E. Jensen, Tzy-Mey Kuo, Matthew Leblanc, Chris D Baggett, Xi Zhou, Katherine E Reeder-Hayes, Jennifer L Lund
Journal: Blood
Blood (2022) 140 (Supplement 1): 5221–5222.
https://doi.org/10.1182/blood-2022-155574
Published: 2022
Journal Articles

Distance to Treatment Center Is Associated with Health Outcomes in Older Adults with AML Receiving Azacitidine and Venetoclax Containing Regimens

Konan E. Beke, Hillary M. Heiling, Christopher E. Jensen, Allison M. Deal, Daniel R. Richardson
Journal: Blood
Blood (2021) 138 (Supplement 1): 1981.
https://doi.org/10.1182/blood-2021-146859
Published: 2021
Journal Articles

Time Spent at Home Among Older Adults with AML Treated with Hypomethylating Agents and Venetoclax

Christopher E. Jensen, Hillary M. Heiling, Konan E. Beke, Allison M. Deal, Ashley Leak Bryant, Lorinda Adaire Coombs, Matthew C. Foster, Daniel R. Richardson
Journal: Blood
Blood (2021) 138 (Supplement 1): 281.
https://doi.org/10.1182/blood-2021-144818
Published: 2021